Preview

Obesity and metabolism

Advanced search

Experience of using Xenical for pilots

https://doi.org/10.14341/omet2008233-37

Abstract

Lack of exercise, hypoxia, stress, constant psychological stress, longer shifts, a violation of the feeding process contribute to the development of metabolic disorders. Thus, persons Summer Special can be seen as a model for the study of risk factors for type 2 diabetes and the development of optimal preventive measures that determined the relevance and purpose of the study. The purpose of research - to evaluate the effectiveness of the correction of overweight and disorders of carbohydrate and lipid metabolism in patients with risk factors for type 2 diabetes. For the correction of body weight was used Orlistat (Xenical) - specific inhibitor of gastrointestinal lipases, acting locally in the lumen of the gastrointestinal trakta.Materialy and methods The study was performed at the Central Clinical Hospital of Civil Aviation. The study found that those aircrew who are overweight are at high risk of developing type 2 diabetes, which is due on the one hand, metabolic disorders due to abdominal obesity, and on the other - especially the professional activity (physical inactivity, a violation of the process food, emotional stress). As an effective therapy to persons aircrew appropriate to recommend treatment with Xenical against the background of a moderately hypocaloric diet combined with the expansion of physical activity.

About the Authors

A S Ametov
Russian medical academy of postdegree education


A A Belykh
Russian medical academy of postdegree education


References

1. Аметов А.С. Инсулиносекреция и инсулинорезистентность: две стороны одной медали. // Проблемы эндокринологии. - 2002. - Т.48. - №3 - С.31-77.

2. Балаболкин М.И., Клебанова Е.М. Роль инсулинорезистентности в патогенезе сахарного диабета типа 2. // Тер. архив. - 2003. - №1. - С.72-77.

3. Балаболкин М.И., Клебанова Е.М., Креминская В.М. Ожирение или синдром избыточной массы тела. В.кн.: Дифференциальная диагностика и лечение эндокринных заболеваний. - М.: Медицина. 2002; 558-95.

4. Дедов И.И. Ожирение: этиология, патогенез, клинические аспекты. / Под ред. И.И. Дедова, Г.А. Мельниченко. - М.: Медицинское информационное агентство, 2004. 456 с.: ил.

5. Дедов И.И. Проблема ожирения: от синдрома к заболеванию. // Ожирение и метаболизм. - 2006. - №1 - С.2-4.

6. Дедов И.И., Мельниченко Г.А., Романцова Т.И. Патогенетические аспекты ожирения. // Ожирение и метаболизм. - 2004. - №3 - С.84-89.

7. Профилактика сахарного диабета: Доклад ВОЗ. Пер. с англ. - М.: Медицина, 1995; 136с.

8. Савельева Л.В. 14 Европейский конгресс по ожирению. Ксеникал: симфония успеха. // Ожирение и метаболизм. - 2006. - №1 - С.53-54.

9. Bloomgarden Z.T. Developments in diabetes and insulin resistance./ Diabetes Care.2006; 29:161-167.

10. European Multicentre Orlistat Study Group. Rаndomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet. 1998; 352:167-72.

11. Hanefeld M., Sachse G. The effects of orlistat on body weight and glycaemic con- trol in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial // Diabetes Oves Metab. 2002; 4:415-423.

12. Kelley D.E., Bray G.A., Pi-Sunyer F.X., et al., Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: a 1-year ran- domized controlled trial. Diabetes Care. 2002; 25:1033-1041.

13. Ryan D.H., Kaiser P., Bray G.A. Sibutramin: a novel new agent for obesity treat- ment. Obes Res. 1995; 3 (Suppl. 4):5535-5595.

14. Torgenson J.S., Hauptman J., Boldrin M.N. et al., Xenical in the prevention of dia- betes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004; 27:151-161.

15. WHO. Prevention and management of the global epidemic of obesity. Report of the WHO Consultation on Obesity (Geneva, 3-5 June, 1997). Geneva: WHO.


Review

For citations:


Ametov A.S., Belykh A.A. Experience of using Xenical for pilots. Obesity and metabolism. 2008;5(2):33-37. (In Russ.) https://doi.org/10.14341/omet2008233-37

Views: 415


ISSN 2071-8713 (Print)
ISSN 2306-5524 (Online)